However, polymorphisms of JAK/STAT3 pathway genes (i.e., JAK2, TYK2, and STAT3) or upstream STAT3 activators (IL-6, IL-11, IL-22, IL6-ST/GP130) confer susceptibility for IBD including CD and UC [6,7,8]. Here, IL6 is linked to inflammatory bowel disease.